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Abstract
Adolescence is a developmental period characterized by unique behavioral phenotypes
(increased novelty seeking, risk taking, sociability and impulsivity) and increased risk for
destructive behaviors, impaired decision making and psychiatric illness. Adaptive and mal-
adaptive adolescent traits have been associated with development of the medial prefrontal
cortex (mPFC), a brain region that mediates regulatory control of behavior. However, the
molecular changes that underlie brain development and behavioral vulnerability have not
been fully characterized. Using high-throughput 2D DIGE spot profiling with identification by
MALDI-TOF mass spectrometry, we identified 62 spots in the PFC that exhibited age-
dependent differences in expression. Identified proteins were associated with diverse cellu-
lar functions, including intracellular signaling, synaptic plasticity, cellular organization and
metabolism. Separate Western blot analyses confirmed age-related changes in DPYSL2,
DNM1, STXBP1 and CFL1 in the mPFC and expanded these findings to the dorsal striatum,
nucleus accumbens, motor cortex, amygdala and ventral tegmental area. Ingenuity Path-
way Analysis (IPA) identified functional interaction networks enriched with proteins identified
in the proteomics screen, linking age-related alterations in protein expression to cellular
assembly and development, cell signaling and behavior, and psychiatric illness. These
results provide insight into potential molecular components of adolescent cortical develop-
ment, implicating structural processes that begin during embryonic development as well as
plastic adaptations in signaling that may work in concert to bring the cortex, and other brain
regions, into maturity.
Introduction
Adolescence is a critical developmental period during which organisms make the transition
from childhood to adulthood. This time period is characterized by significant changes in brain
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architecture [1], pubertal development and sexual maturity, and several unique behavioral
characteristics, including increases in risk-taking, sociability, novelty-seeking, reward sensitiv-
ity and impulsivity [2]. Both the physical and behavioral manifestations of adolescence are
conserved across mammalian species, facilitating the use of rodent models in the study of ado-
lescent development [3]. Adolescence is also a potentially vulnerable time, associated with
increased rates of alcohol and drug use, risky sexual practices, and reckless driving [4]. Addi-
tionally, adolescence in humans and rodents is an epoch of heightened stress, characterized by
increases in anxiety- like behavior as well as enhanced sensitivity of the hypothalamic-pitui-
tary-adrenal axis (HPA axis) response to stressors [5]. Importantly, adolescence is the typical
time of onset of many neurological and psychiatric conditions, including epilepsy, neurode-
generative disorders and neuromuscular dysfunction [6] as well as anxiety, impulse-control,
substance use, schizophrenia and mood disorders [7]. In spite of widespread recognition of
the adaptive and maladaptive changes associated with adolescence, the specific neuronal
mechanisms that usher the brain into adult maturity (and potentially mediate both behavior
and dysfunction) remain unclear.
During adolescence, the brain undergoes substantial structural and functional alteration.
Of considerable significance is the decline of cortical gray matter, which usually begins in late
childhood/early adolescence [8] and may be driven by both synaptic pruning [9] and enhanced
myelination of existing axons [10]. Notably, loss of gray matter density follows an anterior-to-
posterior trajectory, with maturation occurring first in sensorimotor areas and last in higher-
order regions such as the prefrontal cortex (PFC) [11]. The PFC is functionally involved in the
executive control of behavior and decision-making processes [12], and the relative immaturity
of the adolescent PFC is associated with lack of inhibitory control over behavior exhibited by
adolescents [13, 14]. At the same time, limbic brain areas associated with emotional arousal
and reward, such as the amygdala and nucleus accumbens, reach maturity earlier than cortical
regions and receive fewer neural projections from the immature PFC [15], resulting in an
imbalance in top-down control of limbic regions and greater reward seeking and impulsive
behavior in adolescents [16]. The PFC is therefore both a site of significant neuronal develop-
ment during adolescence and a potential contributor to adolescent behavioral phenotypes.
Previous reports have begun to characterize the development of the PFC proteome from
birth to adulthood [17–20], but several important questions have not been addressed by the
existing literature. The specific alterations of protein expression and network function during
adolescence remain unclear, due to the combination of pre-adolescent and adolescent data for
comparison with adults in prior studies. Further, the majority of findings in the developing
PFC to date have focused on the synaptic fraction of proteins. Although this strategy brings
important insight into the development of synaptic connections and signaling during brain
development, proteins that are expressed outside of the membrane fraction may play an
important role in the maturation of the adolescent cortex. Additionally, some studies have
failed to distinguish between the subregions of the PFC collected for analysis. The prelimbic
and infralimbic PFC have different projections and different functional roles in behavior and
therefore may be subject to different developmental processes during the adolescent period
[21]. Finally, previous reports have focused exclusively on the expression of proteins in the
PFC, creating uncertainty as to whether the observed protein expression differences in the
PFC are unique to that region or part of a general developmental trend across multiple brain
regions.
To investigate the subcellular machinery involved in adolescent brain development and
behavior, we used a high-throughput unbiased proteomics analysis to characterize age differ-
ences in protein expression between adolescent and adult male C57BL/6J mice. Mice have a
defined period of adolescence (approximately 2 weeks) in which they display “adolescent
Proteomic analysis of the adolescent and adult mouse mPFC
PLOS ONE | https://doi.org/10.1371/journal.pone.0178391 June 1, 2017 2 / 31
typical” behavior, such as impulsivity and novelty seeking [22], and were therefore a useful
model for these studies. We chose to focus on the transition from early- to mid-adolescence in
order to capture a snapshot of the adolescent brain midway through maturation to adulthood,
and therefore collected tissue on post-natal day (PND) 36 [23]. We focused on the prelimbic
medial prefrontal cortex (mPFC) as this region is critically involved in executive control of
behavior and sends projections to the amygdala and nucleus accumbens [24]. We also used a
bioinformatics approach to identify protein networks that may play a role in adolescent brain
development, particularly neurochemical signaling and structural alterations. By identifying
proteins that are differentially expressed in the adult and adolescent mouse mPFC, as well as
additional brain regions of interest, these experiments give insight into cellular correlates of
adolescent-typical behaviors and dysfunctions.
Materials and methods
Subjects
All procedures were performed in accordance with the NIH Guide to the Care and Use of Lab-
oratory Animals [25] and approved by the Internal Review Board as compliant with all institu-
tional guidelines at the University of North Carolina, Chapel Hill (approved protocol number:
13–217).
Proteomic analysis. Adolescent (postnatal day 21 [PND21]) and adult (PND65 ± 3) male
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were pair-housed upon arrival in stan-
dard laboratory cages with corn-cob bedding and a small PVC tube for environmental enrich-
ment. Food and water were available ad libitum for the duration of the experiment. Subjects
were minimally handled throughout the experiment to minimize stress.
Immunoblotting. An additional group of adolescent (PND 21) and adult (PND 65 ± 3)
male C57BL/6J mice (Jackson) were housed and handled under identical conditions to the
proteomics cohort in order to confirm expression changes observed in the proteomics experi-
ments using Western blots.
Proteomic analysis
Adolescent and adult mouse mPFC proteomes were analyzed utilizing 2-Dimentional in-gel
electrophoresis (2D-DIGE) for protein expression profiling, DeCyder software for selection of
significantly altered spots, and matrix-assisted laser desorption/ionization-Time of Flight
(MALDI-TOF) mass spectrometry (MS) for protein identification (Fig 1D) [26].
Tissue collection. Fifteen days after arrival (Fig 1A), 12 adolescent (P36) and 12 adult
(P80 ± 3) mice were weighed and deeply anesthetized with sodium pentobarbital (150 mg/kg,
IP). Once anesthetized, mice were transcardially perfused with ice-cold phosphate-buffered
saline (PBS, 0.1M, pH 7.4) for 2 min at rate of 3 ml/min in order to remove blood from the
brain tissue. The brain was then quickly isolated and flash-frozen in isopentane (2-methylbu-
tane; Sigma-Aldrich, St. Louis, MO) at -20 –-30˚C for 1 min, weighed, and stored at -80˚C. To
isolate the mPFC, tissue was sliced coronally on a cryostat (Leica CM3050S, Leica Biosystems,
Buffalo Grove, IL), with a 0.5 mm tissue slice being taken between +1.5–2.0 mm (± 0.2) ante-
rior to Bregma. The mPFC was dissected out bilaterally using a 1.0 mm tissue punch (Fig 1C).
The isolated tissue included the prelimbic and dorsal infralimbic cortices, as well as the poste-
rior anterior cingulate cortex. Tissue was pooled from n = 3 mice per age group resulting in a
final group size of N = 4 adolescent and N = 4 adult mPFC samples for analysis on 4 replicate
2D gels. Protein samples were kept at -80˚C and shipped to Applied Biomics (Hayward, CA)
for 2-D DIGE analysis.
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Fig 1. Proteomic analysis of the adolescent and adult medial prefrontal cortex (mPFC). (A) Timeline of experimental
procedure. (B) Adult body weight was significantly greater than adolescent body weight at tissue collection (left), but brain
weight did not differ between the two ages (right). (C) Photomicrograph (left) and schematic (right) of mouse brain section
showing location of mPFC tissue punch for two-dimensional differential in-gel electrophoresis (2D-DIGE) and immunoblot
studies. (D) Schematic describing proteomics workflow. Adult tissue is combined with Cy3 (red) and adolescent with Cy2
(green) dye and run in 2D-DIGE, with protein separating in the y plane via molecular weight and the x plane via isoelectrical
focusing (IEF). DeCyder software identifies protein spots with significantly different florescent signals. Selected spots are
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Tissue preparation. Tissue samples were sonicated on ice in 2D lysis buffer (2 M thio-
urea, 7 M urea, 4% CHAPS, 30 mM Tris-HCl, pH 8.8) and shaken for 30 min at room temper-
ature. Samples were then spun at 14000 rpm at 4˚C for 30 min, and the resulting supernatant
was collected. Protein concentrations were determined using the Bio-Rad protein assay
method (Hercules, CA), and samples were diluted to 5 mg/ml in 2-D lysis buffer.
CyDye labeling. Adult and adolescent tissue samples (30 μg) were combined within age
group with 1.0 μl of the appropriate diluted CyDye (Cy2, Cy3, or Cy5; 1:5 concentration,
diluted with dimethylformamide (DMF) from a 1 nmol/μl stock), vortexed, and kept on ice for
30 min in the dark. Afterwards, 1.0 μl of 10 mM Lysine was added to each sample, vortexed,
and incubated on ice for 15 min in the dark. The CyDye-labeled samples (Cy2, Cy3, Cy5) for
each age group were then combined and mixed with a 2X 2-D sample buffer (8 M urea, 4%
CHAPS, 20 mg/ml dithiothreitol, 2% pharmalytes, trace amount of bromophenol blue) and
100 μl of Destreak Solution and Rehydration Buffer (7 M urea, 2 M thiourea, 4% CHAPS, 20
mg/ml DTT, 1% pharmalytes, trace amount of bormophenol blue) to a final volume of 350 μl
for the 18 cm IPG strip. Labeled samples were mixed well and spun before loading into the
strip holder.
2D-DIGE. Following loading of samples into the 18 cm IPG strip holder, the strip was
placed facing down and 1.5 ml mineral oil was added to the top of the strip. Samples were then
run using isoelectric focusing (IEF) under dark conditions at 20˚C using an established proto-
col (GE Healthcare, Pittsburgh, PA). Following IEF, the IPG strips were incubated in fresh
equilibration buffer 1 (50 mM Tris-HCl, pH 8.8, containing 6 M urea, 30% glycerol, 2% SDS,
trace amount of bromophenol blue, 10 mM DTT) for 15 min with gentle shaking. Strips were
then washed in fresh equilibration buffer 2 (50 mM Tris-HCl, pH 8.8, containing 6 M urea,
30% glycerol, 2% SDS, trace amount of bromophenol blue, and 45 mg/ml lodacetamide) for 10
min with gentle shaking. IPG strips were then washed and transferred to a 12% SDS gel (pre-
pared using low fluorescent glass plates) and sealed with 0.5% w/v agarose solution in SDS-gel
running buffer. Gels were run at 15˚C.
Image scan and data analysis. Immediately following the SDS-PAGE portion of the
2D-DIGE experiment, image scans were conducted using a Typhoon TRIO imager
(GEHealthcare). Scanned images were analyzed by ImageQuantTL (IQTL) software (GE
Healthcare) and subjected to both in-gel and cross-gel analyses using the DeCyder software
package (v. 6.5, GE Healthcare), which provided a ratio change of protein expression from the
in-gel analyses.
Spot picking and trypsin digestion. Protein spots that met our a priori spot-picking crite-
ria (differential expression in the same direction in all four gels, an overall significant differ-
ence in expression [p<0.05], and a 1.2-fold change or greater increase or decrease in
expression) were isolated by the Ettan Spot Picker (GE Healthcare) (Fig 1D). Gel spots were
washed and digested in-gel with a modified porcine trypsin protease (Trypsin Gold, Promega,
Madison, WI). Digested peptides were desalted (Zip-tip C18 column, Millipore, Billerica, MA)
and eluted with 0.5 μl of matrix solution (α-cyano-4-hydroxycinnamic acid, 5 mg/ml in 50%
acetonitrile, 0.1% trifluoroacetic acid, 25 mM ammonium bicarbonate) and spotted on the
matrix-assisted laser desorption/ionization (MALDI) plate.
subjected to tryptan digestion and identified via tandem MALDI TOF/TOF mass spectrometry. (E) Representative 2D-DIGE
gel run in the proteomics analysis of mPFC. Adult samples were combined with red Cydye (left top); adolescent samples were
combined with green CyDye (left bottom). Overlay of adult and adolescent samples (right). IEF is indicated on the x axis with
pH values and molecular weight is indicated on the y axis in kDa. Circles indicate location of differentially expressed spots on
the gel, with numeric markers prior to identification. Focus proteins are indicated in bold, with red representing increased
expression in adults and green representing increased expression in adolescents. (**** indicates p0.0001).
https://doi.org/10.1371/journal.pone.0178391.g001
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Mass spectrometry. Both MALDI-TOF (time-of-flight) mass spectrometry (MS) and
TOF/TOF (tandem MS/MS) analyses were performed on a 5800 mass spectrometer (AB Sciex,
Redwood City, CA). Mass spectra from the MALDI-TOF analysis were acquired in reflectron
positive ion mode (average of 2000 laser shots/spectrum), whereas the TOF/TOF tandem MS
fragmentation spectra were acquired for each sample (average of 2000 laser shots/fragementa-
tion spectrum) on each of the 10 most abundant ions present in the sample (with the exclusion
of trypsin autolytic peptides and other background ions).
Database search. Resulting peptide masses and fragmentation spectra were submitted to
GPS Explorer (v. 3.5) with the MASCOT search engine (Matrix Science, Boston, MA) in order
to explore the database of the National Center for Biotechnology Information non-redundant
(NCBInr). Searches were not constrained by protein molecular weight or isoelectric point;
additionally, the search allowed for variable carbamidomethylation of cysteine and oxidation
of methionine residues, and one missed cleavage was allowed in the search parameters. Both
ion score (statistical likelihood that a peptide sequence experimentally observed and identified
in the MASCOT database are matched based on random chance [-Log10P]) and protein score
(sum of the highest ion scores for each sequence) were calculated; increased protein score indi-
cates increased confidence in the identification of the protein. Candidate proteins with a pro-
tein score confidence interval greater than 95% were considered significant. For samples with
multiple candidate proteins exceeding the identification criteria, an identity was assigned
based on the highest protein score. Full identification data, including all candidate proteins for
each spot, are available on the open access proteomics data repository ProteomeXchange
(www.proteomexchange.org).
Bioinformatics
Pathway analysis. Protein identifiers, fold-change, and p-values from the proteomic anal-
ysis were uploaded to QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN Redwood City,
CA) system for dataset enrichment. A Core Analysis was performed on the dataset, using the
following parameters: reference set- Ingenuity Knowledge Base (genes only), relationships-
direct and indirect, networks- interaction, data sources- all, confidence- experimentally
observed, species- mouse, tissues and cells lines- nervous system/CNS cell lines. Proteins were
assessed via Global Functional Analysis (GFA) and Global Canonical Pathways (GCP) to iden-
tify functional protein networks and canonical signaling systems that were impacted by devel-
opmental state. Statistical significance of the predicted functions and pathways was
determined using the right-tailed Fisher’s Exact Test, where significance indicates that an iden-
tified set of proteins is overrepresented in a set of proteins with known function and is inter-
preted to indicate altered function in the experimental set.
Protein interaction networks were derived via Ingenuity’s interconnectivity algorithm. p
values, representing the probability of finding proteins identified in the proteomics analysis
(Focus Molecules) in a set of n genes randomly selected from the Global Molecular Network,
were calculated using Fisher’s Exact Test and displayed as p-scores [p-score = -log10 (p-value);
i.e. p-score indicates the exponent of the significance of the protein network identification].
Ingenuity Pathway Designer (QIAGEN) was used to visualize the statistically significant pro-
tein interaction networks revealed by GFA.
Immunoblotting: mPFC confirmations and additional brain regions
Tissue collection. Brain tissue was collected from adolescent (P36) and adult (P80 ± 3)
[n = 12/age] as described above. In addition to the mPFC as described, the dorsal striatum
(dSTR), nucleus accumbens (NAc), primary motor cortex (MC), amygdala (AMY) and ventral
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tegmental area (VTA) were isolated and dissected to analyze protein changes in additional
brain areas with relevance to adolescent behavior. The coordinates for each region (relative to
Bregma) were: +1.0–1.5 mm (± 0.2) for dSTR, NAc and M1, -0.9–1.4 mm (± 0.2) for AMY and
-3.3–3.8 mm (± 0.2) for VTA.
Following dissection of regions of interest, tissue punches were homogenized by pulse soni-
cation (4 s) in 10 mM Tris (pH 7.4 at 23˚C) with 1% w/v SDS and 1:100 Halt EDTA-free Prote-
ase and Phosphatase Inhibitor Cocktail (Pierce, ThermoFisher Scientific, Rockford, IL). Brain
tissue was stored at -80˚C. The Pierce BCA kit (ThermoFisher Scientific) was used to deter-
mine protein concentrations (μg/ μL) of each tissue sample.
Immunoblots. Protein samples from each brain region, at 5 μg per sample, were run on a
TGX 4–15% 18-well gel (BioRad) with 1x tris-glycine-SDS running buffer (Tris 25 mM, Gly-
cine 192 mM, 0.1%SDS) with Protein Plus Dual Color (Bio-Rad) and See Blue ladders (Ther-
moFisher Scientific) and dry-transferred onto a PDVF membrane using the Invitrogen iBlot
protocol (ThermoFisher Scientific). Membranes were blocked for 2 hours at room tempera-
ture in 3% bovine serum albumin (BSA, for STXBP1 and DPYSL2; Sigma-Aldrich), 1% BSA
(actin) or 5% w/v non-fat dry milk (for DNM1 and CFL1; ThermoFisher Scientific). Mem-
branes were incubated with the following primary antibodies overnight at 4˚C with gentle
rocking: rabbit polyclonal anti-STXBP1-1 [1:1000 in 3% BSA; Cell Signaling Technology, Inc.,
Danvers, MA], rabbit polyclonal anti-CFL1 [1:5000 in 5% non-fat dry milk, Cell Signaling
Technology, Inc. [27]], mouse monoclonal anti-DNM1 [1:1000 in 5% non-fat dry milk, Cell
Signaling Technology, Inc.]. Blots were incubated with rabbit polyclonal anti-DPYSL2
[1:10,000 in 3% BSA; AbCam, Cambridge, MA [28]] and mouse monoclonal anti-actin
[1:5000; Millipore] for 1 hour at room temperature. Membranes were then extensively washed
and incubated with an HRP-labeled goat-anti rabbit or goat-anti mouse secondary antibody
(1:20,000 in the same blocking buffer as the primary antibody; Jackson ImmunoResearch Lab-
oratories, Inc., West Grove, PA). Protein expression was assessed via an enhanced chemilumi-
nescence protocol (Pierce ECL, ThermoFisher Scientific), with exposure to autoradiography
film (Bio Express, Kaysville, UT). Protein bands were quantified by optical density analysis
(NIH/Scion Image) and normalized to actin which was used as a loading control.
Antibody selectivity for the target protein was established by the vendor (example blots are
available on the manufacturers’ websites.) Prior to immunoblot analysis of experimental tissue,
blots with additional adolescent and adult mouse brain homogenate were probed with each
antibody to validate the vendor’s findings. All antibodies chosen for the confirmation experi-
ments showed a single band at the correct molecular weight marker for the indicated protein.
Actin was chosen as a loading control for these experiments because it was not found to show
differential expression between adolescent and adult mice in the mPFC in the proteomics
screen. To confirm that this housekeeping protein was appropriate, adolescent and adult actin
optical density was compared in all brain regions tested during analysis. No age differences in
actin optical density emerged in any brain region.
Data analysis. Western blot data were analyzed using GraphPad Prism software (Graph-
Pad Software, Inc, La Jolla, CA, v5). To determine the difference between adolescent and adult
mice in the expression of proteins of interest, data were transformed to percent change in opti-
cal density from the adult control for each gel. As the immunoblotting represented a confirma-
tion of the protemics data, significant differences were analyzed by a one-tailed unpaired t-
test, with significance set a priori at p 0.05. Subjects with a percent change less than or
greater than 2 standard deviations away from the group mean were considered outliers and
were removed from the analysis (one adult mouse was removed from the STXBP1 and DNM1
blots, respectively).
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Results
Proteomic analysis
To identify proteins with developmentally altered expression in the mPFC, brains from adoles-
cent (PND 36) and adult (PND 80) mice were collected (Fig 1A). At the time of brain tissue
collection, adolescent body weight was significantly lower than adult mice [t(22) = 8.10, p
<0.0001] but brain weight was equivalent among the two age groups (p> 0.05; Fig 1B). The
mPFC was dissected from each brain (Fig 1C), homogenized and labeled with red (adult) and
green (adolescent) Cy dyes, run on 2D-DIGE, analyzed for expression differences between
ages, and finally identified using tandem MALDI TOF/TOF mass spectrometry (Fig 1D).
The automated proteomic analysis spot picker detected 87 spots with differential expression
in the adolescent and adult mPFC (Fig 1E). Manual curation to fulfil the criteria set (20% dif-
ference in all 4 gels) resulted in 58 differentially expressed spots, while an additional 4 spots
were significantly altered at15% across all 4 gels. All 62 spots were identified using MALDI--
TOF and tandem TOF/TOF mass spectrometry (Table 1). mPFC data were analyzed as adoles-
cent / adult expression, with positive fold change representing decreased protein expression in
adolescents compared to adults and negative fold change representing increased protein
expression in adolescents relative to adults. The majority of the identified proteins fell within
the functional categories of cell-to-cell signaling, cell growth and motility, and cell
metabolism.
Ingenuity pathway analyses
All proteins identified in the proteomics analysis were uploaded to Ingenuity Pathway Analysis
for Global Functional Analysis (GFA) and Global Canonical Pathway (GCP) determination
(Table 2). GFA revealed participation of identified proteins in cellular functions including cell-
to-cell signaling and interaction, cellular morphology and cellular development. Additionally,
identified proteins were shown to be involved in neurological disease, including schizophrenia
and movement disorders. GCP analysis indicated the involvement of identified proteins in
several known signaling cascades, including semaphoring signaling and axonal guidance sig-
naling, androgen signaling, and glycolysis I and gluconeogenesis I signaling.
Network analysis and Western blot confirmation
Ingenuity Pathway Analysis was performed to identify functional protein networks likely to be
impacted by the developmentally regulated proteins identified in the proteomics analysis.
Three significant networks were identified: Network 1, cellular assembly and organization, cel-
lular function and maintenance, and cellular movement (p-score 29); Network 2, behavior, cell
signaling and interaction, nervous system development and function (p-score 31); Network 3,
neurological disease, skeletal and muscular disorders, and psychological disorders (p-score
22). Complete Western blot gel images for all proteins tested are shown in supporting informa-
tion figures (S1–S24 Figs).
Network 1. Network 1 (Cellular Assembly & Organization) includes 18 focus molecules
identified in the proteomics analysis of adolescent and adult mPFC as well as 17 significant
interaction proteins (Fig 2). Noteworthy predicted regulators of this network include inter-
feron gamma (INFG) and reticulon 4 (RTN4).
Of the focus molecules, dihydropyrimidinase-like 2 (DPYSL2) was a locus of significant
interconnectedness in Network 1 and was thus selected for further analysis. DPYSL2 appeared
at Spot 12 in the proteomics analysis (Fig 1E), where its standardized log abundance was 0.041
in adults and -0.098 in adolescents, representing a 38% reduction in adolescents versus adults
Proteomic analysis of the adolescent and adult mouse mPFC
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Table 1. 62 Differentially expressed proteins in adult versus adolescent mPFC Identified in proteomics analysis.
Protein Name Gene ID Spot # Peptide
Count
Protein
Score
Relative
Change
p
Value
Fatty acid-binding protein FABP7 62 7 368 -2.14 < 0.0001
Neurocalcin-δ NCALD 75 9 328 -1.76 < 0.0001
Dihydropyrimidinase-like 3 DPYSL3* 18 16 209 -1.72 < 0.0001
ATP synthase subunit delta ATP5D 58 3 178 -1.70 < 0.0001
β-synuclein SNCB 56 6 503 -1.68 0.0014
Dihydropyrimidinase-like 5 DPYSL5 23 22 675 -1.61 < 0.0001
Clathrin light chain A CLTA 36 8 220 -1.60 < 0.0001
Cofilin-1 CFL1 54 9 158 -1.58 0.00028
Phosphoglycerate mutase 1 PGAM1 44 17 817 -1.54 0.0066
Membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) MPP2 17 19 421 -1.52 < 0.0001
Protein kinase C γ PRKCG* 8 19 195 -1.51 0.013
Glyceraldehyde-3-phosphate dehydrogenase GAPDH* 38 10 318 -1.51 0.0054
Protein phosphatase 3, regulatory subunit B, alpha PPP3R1* 60 10 171 -1.48 0.0014
Growth associated protein 43 GAP43 31 9 201 -1.46 0.00048
Dihydropyrimidinase-like 4 DPYSL4 22 24 1030 -1.43 0.00022
Calreticulin CALR 15 19 740 -1.42 0.00081
Dihydropyrimidinase-like 3 DPYSL3* 19 14 291 -1.42 < 0.0001
Protein phosphatase 3, regulatory subunit B, alpha PPP3R1* 59 12 600 -1.40 0.011
Protein kinase C γ PRKCG* 9 21 392 -1.40 0.021
Fascin actin-bundling protein 1 FSCN1 24 17 674 -1.37 < 0.0001
Drebrin DBN1 72 23 858 -1.34 0.0018
Collapsin Response Mediator Protein 1 CRMP1 21 20 515 -1.33 < 0.0001
CB1 cannabinoid receptor-interacting protein 1 CNRP1 53 9 594 -1.32 0.033
3-oxoacid CoA transferase 1 OXCT1* 25 7 359 -1.32 < 0.0001
3-oxoacid CoA transferase 1 OXCT1* 26 14 891 -1.29 < 0.0001
Fatty acid-binding protein FABP5 63 11 438 -1.28 < 0.0001
Voltage-dependent anion-selective channel protein 3 VDAC3 50 11 613 -1.27 0.0014
Dynamin-1 DNM1* 6 34 625 -1.25 0.0022
Synapsin II SYN2 27 13 328 -1.24 0.0016
Guanine nucleotide binding protein (G protein), beta polypeptide 4 GNB4 37 15 231 -1.23 0.0028
HYDIN, axonemal central pair apparatus protein HYDIN 82 21 41 -1.23 0.0078
Clathrin, light chain B CLTB 74 13 424 -1.23 0.0096
Calbindin 2 CALB2 41 14 388 -1.22 0.014
3-hydroxybutyrate dehydrogenase, type 1 BDH1 49 12 489 -1.22 0.013
Fatty acid binding protein 3 FABP3 71 8 421 -1.20 0.0017
Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 GNB2L1 68 18 972 -1.17 0.00024
Dihydropyrimidinase-like 2 DPYSL2* 14 28 878 1.14 0.00088
Enolase 2 (gamma, neuronal) ENO2 30 19 861 1.18 0.0019
Creatine kinase, brain CKB 32 21 881 1.18 < 0.0001
Ubiquinol-cytochrome c reductase core protein II UQCRC2 69 16 465 1.19 0.017
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial NDUFV1 77 18 380 1.20 < 0.0001
EF-hand domain-containing protein D2 EFHD2 40 10 302 1.21 0.004
Bridging integrator 1 BIN1 10 22 801 1.22 0.015
V-type proton ATPase subunit B, brain isoform VATB2 81 12 87 1.23 0.0022
Pyruvate kinase isozymes M1/M2 KPYM 80 24 624 1.24 < 0.0001
Voltage-dependent anion-selective channel protein 1 VDAC1* 47 7 540 1.25 0.0015
(Continued )
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(Fig 3A–3C). Spot 12 was identified as DPYSL2 with a protein score of 800 (Table 1), and no
other candidate proteins met the pre-hoc criteria for identification at Spot 12. Western blot
analysis confirmed the decrease observed in the proteomics analysis, with adolescent expres-
sion of DPYSL2 27% in mPFC lower than adult [t(26) = 2.27, p<0.05; Fig 3D and 3E].
In addition to the results of the proteomic analysis and Western blots in the mPFC, other
brain regions were of interest based on their association with adolescent-typical behaviors.
The dorsal striatum (dSTR), nucleus accumbens (NAc), primary motor cortex (MC), amyg-
dala (AMY) and ventral tegmental area (VTA) were also analyzed for expression of the selected
confirmation proteins. DPYSL2 expression was significantly reduced in adolescent mice as
compared with adult mice in all brain regions examined excepting the VTA (p>0.05; Fig 3F).
Age differences were most pronounced in the MC [22% decrease; t(23) = 9.00, p<0.0001] and
AMY [26% decrease; t(19) = 4.45, p<0.0001], with less pronounced differences in the dSTR
[18% decrease; t(22) = 3.59, p<0.001] and NAc [9% decrease; t(23) = 2.42, p<0.05].
Dynamin-1 (DNM1) was also significantly interconnected in Network 1 and was subse-
quently analyzed. In the proteomics analysis DNM1 was identified twice, at Spot #4 and Spot
#6 (Fig 1E). At Spot 4, DNM1 standardized log abundance was -0.003 for adults and -0.056 for
adolescents, representing a 31% decrease in adolescent mice compared to adults (Fig 4A–4C).
Spot 4 was identified as DNM1 with a peptide score of 338 (Table 1), and no other candidate
proteins met the pre-hoc criteria for identification at Spot 12. At Spot 6, DNM1 standardized
log abundance was -0.058 for adults and 0.400 for adolescents, representing a 26% increase in
adolescent mice compared to adults (Fig 4D–4F). At Spot 6, the candidate proteins DNM1 and
DNM2 both exceeded the pre-hoc criteria of 95% C.I., and DNM1 was selected as the identity
for Spot 6 based on the higher peptide score for DNM1 (625) versus DNM2 (83). Western blot
analysis indicated that DNM1 expression was decreased by 22% in adolescent mPFC as
Table 1. (Continued)
Protein Name Gene ID Spot # Peptide
Count
Protein
Score
Relative
Change
p
Value
Syntaxin-binding protein 1 STXB1* 79 26 716 1.26 0.0002
Guanine nucleotide-binding protein G(o) subunit α GNAO1 35 13 647 1.27 < 0.0001
Glutathione S-transferase mu 5 GSTM5 73 18 639 1.28 < 0.0001
N-ethylmaleimide-sensitive factor NSF 78 21 280 1.29 0.0078
Voltage-dependent anion-selective channel protein 1 VDAC1* 67 13 611 1.29 0.00029
Dynamin-1 DNM1* 4 22 338 1.31 0.00078
Septin-3 SEPT3 34 6 103 1.32 < 0.0001
Mitochondrial inner membrane protein IMMT 7 28 625 1.32 0.00026
Carbonic anhydrase 2 CAH2 46 13 615 1.34 < 0.0001
Dihydropyrimidinase-like 2 DPYSL2* 13 25 719 1.35 0.00012
Cysteine and glycine-rich protein 1 CSRP1 51 8 334 1.36 0.017
Dihydropyrimidinase-like 2 DPYSL2* 12 26 800 1.38 < 0.0001
Syntaxin-binding protein 1 STXB1* 20 28 788 1.39 < 0.0001
Complexin-2 CPLX2 57 6 163 1.41 0.018
Septin-2 SEPT2 33 10 352 1.48 0.00058
Glyceraldehyde-3-phosphate dehydrogenase GAPDH* 48 12 280 4.33 < 0.0001
58 spots showed20% difference in expression in all 4 2D-DIGE gels (p<0.05; standard font), with an additional 4 spots with15% difference in
expression in all 4 2d-DIGE gels (p<0.05; italics). Each spot was identified via MALDI TOF/TOF mass spectrometry with a confidence of 1.0. Spot change
was expressed as fold change ratio of adolescent from adult, with negative numbers reflecting an reduced expression in adults relative to adolescents and
positive numbers indicating greater expression in adults. Asterisks denote spots that appear more than once in the proteomics report.
https://doi.org/10.1371/journal.pone.0178391.t001
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Table 2. Role of identified proteins in biofunctions and disorders, and canonical signaling networks.
Biofunctions and disorders
Function/Disorder p-Value Higher in adults Higher in adolescents
Cell-to-cell Signaling and
Interaction
Synaptic transmission of synapse 0.000033 STXBP1,VDAC1 SNCB,VDAC3
Synaptic transmission of nervous
tissue
0.0000549 NSF,STXBP1,VDAC1 SNCB,VDAC3
Synaptic transmission 0.00000124 NSF,STXBP1,VDAC1 PPP3R1,SNCB,SYN2,VDAC3
Long-term potentiation of synapse 0.00000198 CPLX2,VDAC1 CALB2,CRMP1,PPP3R1,
PRKCG, VDAC3
Long-term potentiation 0.00000453 CPLX2,VDAC1 CALB2,CRMP1,DPYSL4,
PPP3R1,PRKCG,VDAC3
Synaptic depression 0.0122 PPP3R1,PRKCG,SYN2
Cellular Morphology p-Value Higher in adults Higher in adolescents
Size of neurons 0.00333 DPYSL3,GAP43,SNCB
Morphology of neurites 0.0187 CKB DPYSL4,GAP43
Morphology of neurons 0.00716 CKB,DNM1 CRMP1,DPYSL4,DPYSL5,
GAP43
Length of neurites 0.00173 DPYSL2 DPYSL3,DPYSL4
Length of neurons 0.000214 DPYSL2 DBN1,DPYSL3,DPYSL4
Formation of filopodia 0.0000124 CSRP1 DPYSL3,DPYSL5
Extension of plasma membrane
projections
0.0213 DPYSL2 DBN1,DPYSL5
Outgrowth of neurites 0.011 DPYSL2,GNAO1 DPYSL3,DPYSL5,GAP43
Branching of neurons 0.000225 CSRP1,DPYSL2 CRMP1,DBN1,DPYSL3,DPYSL4,
GAP43
Morphogenesis of neurites 0.00276 CSRP1,DPYSL2,SEPT2 CRMP1,DBN1,DPYSL4,GAP43
Dendritic growth/branching 0.00244 CSRP1 CRMP1,DBN1,DPYSL4,GAP43
Branching of neurites 0.00125 CSRP1,DPYSL2 CRMP1,DBN1,DPYSL4,GAP43
Morphology of cells 0.00137 CKB,DNM1 CRMP1,DPYSL3,DPYSL4,
DPYSL5,GAP43,SNCB
Size of brain 0.0248 CKB FSCN1,GAP43
Cellular Development p-Value Higher in adults Higher in adolescents
Abnormal morphology of cerebral
cortex
0.00591 CKB,CPLX2 CRMP1,GAP43
Abnormal morphology of brain 0.0138 CKB,CPLX2 CRMP1,GAP43,SNCB,SYN2
Abnormal morphology of nervous
system
0.0332 CKB,CPLX2,DNM1 CRMP1,GAP43,SNCB,SYN2
Morphology of nervous system 0.00607 CKB,CPLX2,DNM1 CRMP1,DPYSL4,DPYSL5,
GAP43,SNCB,SYN2
Proliferation of cells 0.00297 CSRP1,DPYSL2,GNAO1,
PKM
CFL1,DPYSL3,DPYSL5,FABP7,
GAP43
Proliferation of neuronal cells 0.00476 CSRP1,DPYSL2,GNAO1 CFL1,DPYSL3,DPYSL5,GAP43
Differentiation of cells 0.0014 CSRP1,DPYSL2 CRMP1,DBN1,DPYSL3,DPYSL4,
FABP7,GAP43
Transport of synaptic vesicles 0.00000475 BIN1,CPLX2,DNM1,DPYSL2 SNCB
Endocytosis of synaptic vesicles 0.000186 BIN1,DNM1 SNCB
Growth of neurites 0.0056 CSRP1,DPYSL2,GNAO1 DPYSL3,DPYSL5,GAP43
Neurological Disease p-Value Higher in adults Higher in adolescents
Neuromuscular disease 0.000121 CA2,CKB,ENO2 DPYSL3,FABP7,GAP43,
PPP3R1,PRKCG
(Continued )
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compared to adults [t(25) = 5.84, p<0.0001; Fig 4G and 4H]. DNM1 expression was also sig-
nificantly lower in adolescents compared with adults in dSTR [12% decrease; t(22) = 4.48; p
<0.0001], MC [13% decrease; t(23) = 5.48, p<0.0001], AMY (14% decrease; t(18) = 2.73, p
<0.01] and VTA (9% decrease; t(21) = 2.68, p<0.01, Fig 4I]. The NAc displayed no age differ-
ences in DNM1 expression (p>0.05).
Network 2. Network 2 (Behavior/Signaling) includes 19 focus molecules identified in the
proteomics analysis as well as 16 proteins statistically predicted to interact with the focus pro-
teins in a functional network (Fig 5). Of the focus molecules, 9 exhibited higher expression in
adult mPFC whereas 10 exhibited greater expression in adolescents Notable predicted regula-
tors of this network include brain-derived neurotrophic factor (BDNF) and huntingtin (HTT).
Of the focus molecules identified in the proteomics analysis in Network 2, syntaxin-binding
protein 1 (STXBP1) was a significant hub of interconnectedness within the network and was
therefore selected for further analysis. In the proteomics analysis of the mPFC STXBP1 was
identified twice, at spot #20 and spot #79 (Fig 1E). At Spot 20, STXBP1 standardized log abun-
dance was 0.039 for adults and -0.100 for adolescents, representing a 39% decrease in
Table 2. (Continued)
Schizophrenia 0.00000118 ATP6V1B2,CSRP1,VDAC1 CLTB,GAP43,OXCT1,PGAM1,
SNCB
Disorder of basal ganglia 0.000117 CA2,CKB,ENO2 DPYSL3,FABP7,GAP43,
PPP3R1,PRKCG
Movement Disorders 0.00014 CA2,CKB,ENO2 DPYSL3,FABP7,GAP43,
PPP3R1,PRKCG
Huntington’s Disease 0.000119 CA2,CKB,ENO2 DPYSL3,FABP7,PPP3R1,
PRKCG
Canonical pathways and upstream regulators
Pathways p Value Higher in adults Higher in adolescents
Semaphorin Signaling in Neurons 2.31E-08 DPYSL2 CRMP1,CFL1,DPYSL3,DPYSL4,
DPYSL5
Glycolysis I 7.01E-07 PKM,ENO2,GAPDH PGAM1
Huntington’s Disease Signaling 8.93E-07 DNM1,NSF,CPLX2 CLTA,CLTB,GNB2L1,GNB4,
PRKCG
Androgen Signaling 4.05E-05 GNAO1 CALR,GNB4,GNB2L1,PRKCG
Gluconeogenesis I 4.84E-05 ENO2,GAPDH PGAM1
Axonal Guidance Signaling 7.26E-05 DPYSL2,GNAO1 GNB4,CFL1,PPP3R1,GNB2L1,
DPYSL5,PRKCG
Regulators
MAPT 1.15E-16 CKB,CPLX2,DPYSL2,ENO2,GAPDH,GNAO1,PKM,
STXBP1,VDAC1,
ATP5D,CFL1,CLTA,CLTB,
PGAM1,SNCB
APP 3.88E-15 CKB,CPLX2,DNM1,DPYSL2,ENO2,GAPDH,GNAO1,PKM,
STXBP1,VDAC1
ATP5D,CFL1,CLTA,CLTB,DBN1,
FABP3,GAP43,PGAM1,SNCB,
SYN2
PSEN1 7.74E-14 CKB,CPLX2,DPYSL2,ENO2,GAPDH,GNAO1,PKM,
STXBP1,VDAC1
ATP5D,CFL1,CLTA,CLTB,
PGAM1,SNCB
MKNK1 2.84E-08 CPLX2,GNAO1,STXBP1 CRMP1,DPYSL3,GAP43,SYN2
BDNF 6.22E-08 CPLX2,GNAO1,STXBP1 CALB2,CRMP1,DPYSL3,FSCN1,
GAP43,SYN2
Proteomics results were analyzed via Ingenuity Pathway Analysis for known interactions with other proteins, signaling systems and networks in the
Ingenuity Knowledge Base. Proteins that displayed higher expression during adulthood are shown on the left, and proteins that displayed higher expression
during adolescence are shown on the right, as seen in Table 1. p values were derived from Ingenuity Pathway Analysis by right-tailed Fisher exact test and
indicate relative overrepresentation of proteins in a given function compared with what is expected by chance.
https://doi.org/10.1371/journal.pone.0178391.t002
Proteomic analysis of the adolescent and adult mouse mPFC
PLOS ONE | https://doi.org/10.1371/journal.pone.0178391 June 1, 2017 12 / 31
adolescent mice compared to adults (Fig 6A–6C). Spot 20 was identified as STXBP1 with a
peptide score of 788, and no additional candidate proteins met the pre-hoc criteria for identifi-
cation at that spot. At Spot 79, the candidate proteins STXBP1 and TPX2 both exceeded the
pre-hoc criteria of 95% C.I., and STXBP1 was selected as the identity of Spot 79 based on the
Fig 2. Adolescent development impacts a functional protein network involved in cellular assembly and organization, cellular
function and maintenance, and cellular movement. Visualization of a protein interaction network identified by Ingenuity Pathway
Analysis as being altered by adolescent brain development (p-score = 29). Proteins shown in red were up-regulated in the adult mPFC,
proteins in green were up-regulated in the adolescent mPFC, and proteins in yellow indicate statistically significant interaction proteins
identified by IPA network analysis. Solid lines indicate a direct interaction, and dashed lines indicate an indirect interaction mediated by
additional, non-significant proteins. Asterisks denote proteins that were identified multiple times in the proteomic analysis that have been
consolidated into a single point in the functional network. Molecules for confirmation are indicated in bold, e.g. syntaxin binding protein 1
(STXBP1), dynamin-1 (DNM1) and dihydropyrimidinase-like-2 (DPYSL2).
https://doi.org/10.1371/journal.pone.0178391.g002
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Fig 3. Adult and adolescent expression of dihydropyrimidinase-like-2 (DPYSL2). (A) Representative 3D plot of
DPYSL2 expression in adult (left) and adolescent (right) mice for Spot #20. (B) Standardized abundance (log) of
DPYSL2 demonstrating higher expression in adults versus adolescents. (C) Representative gel image of a Western
blot for DPYSL2 expression to confirm 2D-DIGE changes. Both resulting bands were quantified. (D) Quantification of
Western blot results, confirming reduced expression of DPYSL2 (normalized to actin) in adolescents as compared to
adults. (E) Top, representative gel images for each brain region; bottom, quantification of Western blots for each brain
region. Adults show increased expression of DPYSL2 in dStr, NAc, MC and Amy. No significant age differences were
Proteomic analysis of the adolescent and adult mouse mPFC
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higher peptide score of STXBP1 (716) versus TPX2 (65). STXBP1 standardized log abundance
was 0.036 for adults and -0.058 for adolescents, representing a 26% decrease in adolescent
mice compared to adults (Fig 6D–6F). Western blot analysis confirmed the decreases observed
in the proteomics analysis with adolescent expression of STXBP1 18% lower than adult expres-
sion in mPFC [t(25) = 3.89, p<0.001; Fig 6G and 6H]. STXBP1 expression was consistently
reduced in adolescent mice as compared to adult mice in all brain regions examined (Fig 6I).
The age difference was most pronounced in MC, where adolescent STXBP1 expression was
decreased by 39% compared to adults [t(23) = 7.85, p<0.0001]. Age differences in the dSTR
[11% decrease; t(23) = 3.98, p<0.001], NAc [17% decrease; t(23) = 3.35, p<0.01], AMY [11%
decrease; t(18) = 2.48, p<0.05] and VTA [15% decrease; t(21) = 3.91, p<0.001] were more
modest.
Network 3. Network 3 (Disease) includes 15 focus molecules identified in the proteomics
analysis that were differentially expressed in adolescent as compared to adult mPFC as well as
20 significant interaction proteins (Fig 7). Of the focus molecules, 8 exhibited greater expres-
sion in adults whereas 7 had greater expression in adolescents. Significant predicted regulators
of this network included amyloid-β precursor protein (APP), microtubule-associated protein
tau (MAPT) and presenilin-1 (PSEN1).
The focus molecule cofilin-1 (CFL1) was a significant component of the network connectiv-
ity and was selected for further analysis. CFL1 appeared at Spot 54 in the proteomics analysis
of the mPFC (Fig 1E), where its standardized log abundance was -0.378 in adults and -0.180 in
adolescents, representing a 58% increase in adolescents versus adults (Fig 8A–8C). Both the
candidate proteins CFL1 and CFL2 exceeded the pre-hoc criteria for identification, and CFL1
was chosen as the identity for Spot 54 based on the higher peptide score of CFL1 (158) versus
CFL2 (149). Western blot analysis confirmed the increase observed in the proteomics analysis,
with adolescent expression of CFL1 21% higher than adult [t(26) = 1.84, p<0.05; Fig 8D and
8E] in the mPFC. CFL1 expression was also significantly higher in adolescents versus adults in
the VTA [23% increase; t(21) = 1.85, p<0.05; Fig 8F). No significant age differences in CFL1
emerged in the dSTR, NAc, MC or AMY (p>0.05).
Discussion
Although significant structural changes in the prefrontal cortex during adolescence have been
well established, the molecular changes that mediate these developmental alterations remain to
be more fully characterized. The present study utilized a high-throughput unbiased proteomics
approach to identify specific proteins and protein networks that show differential expression
in adolescent compared to adult mPFC. 2D-DIGE followed by MALDI TOF/TOF identified
62 individual proteins with significant age-dependent differences in expression. Ingenuity
Pathway Analysis identified 3 networks in which these target proteins were overexpressed.
Further results confirmed key changes from previous investigations [20] while focusing the
analysis on adolescent-specific protein changes, and extended these findings in additional
brain regions (dSTR, MC, NAc, AMY and VTA). Together, the results indicate that, compared
to adults, the adolescent mPFC has developmentally linked alterations in protein networks
that regulate cellular organization/structure, neuronal signaling, anxiety-related behavior and
neurological disease. These findings strengthen existing hypotheses about the progression of
postnatal cortical development and point to several novel potential functional regulators of
adolescent-typical behavior and vulnerability.
observed in the VTA (p>0.05). Data were expressed as percent change from mean adult within the same blot and
graphed as mean ± SEM. (* indicates p0.05, *** indicates p0.001).
https://doi.org/10.1371/journal.pone.0178391.g003
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Fig 4. Adult and adolescent expression of dynamin-1 (DNM1). (A) Representative 3D plot of DNM1 expression in adult (left) and
adolescent (right) mice for Spot #4. (B) Standardized abundance (log) of DNM1 (Spot 4) demonstrating higher expression in adults versus
adolescents (C) Representative 3D plot of DNM1 expression in adult (left) and adolescent (right) mice for Spot #6. (D) Standardized
abundance (log) of DNM1 (Spot 6) demonstrating higher expression in adults versus adolescents. (E) Representative gel image of a
Western blot for DNM1 expression to confirm 2D-DIGE changes. (F) Quantification of Western blot results, confirming reduced expression
of DNM1 (normalized to actin) in adolescents as compared to adults. (G) Top, representative gel images for each brain region; bottom,
quantification of Western blots for each brain region. DNM1 expression was higher in adults in dStr, M1, Amy, and VTA. There was no
significant change in DNM1 expression in NAc (p>0.05). Data were expressed as percent change from mean adult within the same blot and
graphed as mean ± SEM. (* indicates p0.05, ** indicates p0.01, *** indicates p0.001, **** indicates p0.0001).
https://doi.org/10.1371/journal.pone.0178391.g004
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Structural development
The present results provide several lines of evidence that suggest that the adolescent mPFC is
characterized by widespread alterations in protein expression related to the regulation of cellu-
lar assembly & structure, cellular organization and structural plasticity. Many of the proteins
identified in the proteomic analysis have roles in cellular morphology and synaptic plasticity.
Ingenuity Global Canonical Pathway analysis also suggested that canonical signaling pathways
Fig 5. Adolescent development impacts a functional protein network involved in behavior, cell-to-cell signaling and interaction,
and nervous system development and function. Visualization of a protein interaction network identified by Ingenuity Pathway Analysis
as being altered by adolescent brain development (p score = 31). Proteins shown in red were up-regulated in the adult mPFC, proteins in
green were up-regulated in the adolescent mPFC, and proteins in yellow indicate statistically significant interaction proteins identified by IPA
network analysis. Solid lines indicate a direct interaction, and dashed lines indicate an indirect interaction mediated by additional, non-
significant proteins. Asterisks denote proteins that were identified multiple times in the proteomic analysis that have been consolidated into a
single point in the functional network. Focus molecule syntaxin binding protein 1 (STXBP1) is indicated in bold.
https://doi.org/10.1371/journal.pone.0178391.g005
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Fig 6. Adult and adolescent expression of syntaxin binding protein 1 (STXBP1). (A) Representative 3D plot of STXBP expression in
adult (left) and adolescent (right) mice for Spot #20. (B) Standardized abundance (log) of STXBP1 (Spot 20) demonstrating higher
expression in adults versus adolescents. (C) Representative 3D plot of STXBP1 expression in adult (left) and adolescent (right) mice for
Spot #79. (D) Standardized abundance (log) of STXBP1 (Spot 79) demonstrating higher expression in adults versus adolescents. (E)
Representative gel image of a Western blot for STXBP1 expression to confirm 2D-DIGE changes. (F) Quantification of Western blot results,
confirming reduced expression of STXBP1 (normalized to actin) in adolescents as compared to adults. (G) STXBP1 expression was greater
in adults in dStr, NAc, M1, Amy, and VTA. Top, representative gel images for each brain region; bottom, quantification of Western blots for
each brain region. (*** indicates p0.001, **** indicates p0.0001.)
https://doi.org/10.1371/journal.pone.0178391.g006
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known to regulate cellular growth and development in the adult mPFC were likely to differ
from the adolescent condition, based on the interactions between proteins identified in the
proteomics screen (Table 2). Both semaphorin signaling and axonal guidance signaling were
identified as canonical signaling pathways that were impacted by the developmental state of
the mPFC (Table 2). The majority of identified proteins in these canonical pathways were up-
regulated in the adolescent cortex. Semaphorins are a family of receptors and secretory pro-
teins that have a well-established role in guiding axonal outgrowth during embryonic develop-
ment [29] and are also involved in neuronal maturation, synaptic plasticity and cell death in
the adult cortex [30, 31]. Although the role of sempahorin signaling in adolescent brain matu-
ration and synaptic pruning has not been investigated to date, this signaling system is a plausi-
ble mediator of morphological changes in adolescent cortex and merits examination in future
studies.
Fig 7. Adolescent development impacts a functional protein network involved with neurological disease, skeletal and muscular
disorders, and psychological disorders. Visualization of a protein interaction network identified by Ingenuity Pathway Analysis as being
altered by adolescent brain development (p-score = 22). Proteins shown in red were up-regulated in the adult mPFC, proteins in green were
up-regulated in the adolescent mPFC, and proteins in yellow indicate statistically significant interaction proteins identified by IPA network
analysis. Solid lines indicate a direct interaction, and dashed lines indicate an indirect interaction mediated by additional, non-significant
proteins. Asterisks denote proteins that were identified multiple times in the proteomic analysis that have been consolidated into a single
point in the functional network. Focus molecule cofilin-1 (CFL1) is indicated in bold.
https://doi.org/10.1371/journal.pone.0178391.g007
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Fig 8. Adult and adolescent expression of cofilin-1 (CFL1). (A) Representative 3D plot of CFL1 expression
in adult (left) and adolescent (right) mice for Spot #54. (B) Standardized abundance (log) of CFL1 demonstrating
higher expression in adults versus adolescents. (C) Representative gel image of a Western blot for CFL1
expression to confirm 2D-DIGE changes. (D) Quantification of Western blot results, confirming reduced
expression of CFL1 (normalized to actin) in adolescents as compared to adults. (E) Top, representative gel
images for each brain region; bottom, quantification of Western blots for each brain region. Adolescents show
higher expression of CFL1 in VTA. There were no significant changes in CFL1 expression in dSTR, NAc, MC or
Amy (p>0.05). (* indicates p0.05, *** indicates p0.001).
https://doi.org/10.1371/journal.pone.0178391.g008
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Ingenuity Pathway Analysis identified a functional protein network involved in cellular
assembly and organization that was significantly impacted by age (Fig 2). Several proteins
identified in this network have been shown to play a role in synaptic development, including
PP3R1 [32], CALR [33] and NSF [34], as well as the focus protein DPYSL2. DPYSL2 (or
CRMP2) is a member of the CRMP family, which binds tubulin heterodimers to facilitate
microtubule assembly [35]. These proteins function in growth cone formation, contributing to
neuronal outgrowth [36] and may also play a role in cell death [37] and thus neural pruning.
The expression of CRMP1 and DPYSL3, 4, and 5 was higher in the adolescent mPFC, consis-
tent with increased neuronal outgrowth and synaptic formation during this developmental
period (Table 1). However, DPYSL2 expression was found to be consistently higher in adults
in the mPFC, dSTR, NAc, M1, and AMY (Fig 4). The reason why this CRMP subtype, but not
the others, is up-regulated in adulthood is unknown, but could be due to a developmental shift
from dominant expression of CRMP 1, DPYSL3, 4, or 5 in the adolescent brain to DPYSL2 in
the adult brain. DPYSL2 was identified three times in the proteomic screen, at spots #12, 13
and 14. Spots 13 and 14 appeared at the same molecular weight range but exhibited different
isoelectrical focusing, which may suggest a posttranslational modification affecting one of the
two spots. Spot #12 exhibited shifts in both isoelectrical focusing and molecular weight, which
could indicate a possibility of protein contamination, significant posttranslational modifica-
tion, or both. Immunoblots confirmed the increase in total DPYSL2 in the adolescent mPFC,
but additional assessment with antibodies targeting posttranslational modifications of
DPYSL2 would provide clarity as to the variable spots detected in the proteomics screen.
Signaling and behavior
In addition to their roles as mediators of cellular assembly and development, many of the pro-
teins identified in the proteomics analysis are known to be involved in cell-to-cell signaling
and neurotransmission. Indeed, Ingenuity Pathway Analysis identified a significant protein
interaction network associated with cell signaling and behavior that was impacted by adoles-
cent brain maturation (Fig 4). The immaturity of the prefrontal cortex has been suggested to
underlie many adolescent-typical behaviors, such as impulsivity, reward sensitivity and risk
taking. Subcortical areas involved in emotional processing (such as the nucleus accumbens,
ventral tegmental area and amygdala) reach adulthood before regulatory control of these
regions from the PFC is fully mature [16], leading to enhanced response to reward and impair-
ments in inhibitory control under emotionally salient conditions [38].
At the cellular level, previous studies have demonstrated that the adolescent mPFC has
altered responses to neurotransmitters and cell signaling molecules, including dopamine [39,
40], glutamate [41] and GABA [42]. Moreover, several studies have provided evidence for the
regulation of adolescent-typical behaviors by diverse signaling systems including the cannabi-
noid systems [43], glutamate [44], dopamine [45] and GABA [46]. Within the network identi-
fied by IPA, several proteins with established roles in adolescent-related behaviors were
observed, including BDNF [47, 48], GAP43 [49] and mTOR [50]. Regulation of both PFC
function and behavior by these varied signaling systems may reflect large-scale structural
changes occurring in the adolescent forebrain during development, consistent with the alter-
ations in structural proteins we observed.
The focus proteins STXBP1 and DNM1 have both been shown to be involved in neuro-
transmitter signaling, and both displayed different expression patterns in the adolescent and
adult mPFC. STXBP1 contributes to the regulation of exocytosis in cells, assisting in vesicle
fusion and neurotransmitter release [51]. The proteomics screen revealed two individual spots
that were each identified as STXBP1 (spot #20 and #79), both of which displayed decreased
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expression in adolescents versus adults (Fig 6). While it is possible that these multiple spots
could represent contamination with other proteins, each spot was identified as STXBP1 with
high confidence; spot #20 was identified as STXBP1 with 28 peptides and a peptide score of
788, and spot #79 was identified as STXBP1 with 26 peptides and a peptide score of 716. Based
on these identifications, another explanation for the multiple identifications of STXBP1 in the
proteomics screen is post-translational modifications. The presence of phosphate groups,
methylation and other post-translational modifications can shift the isoelectrical focusing of a
spot without altering the observed molecular weight or peptide identification. Immunoblotting
confirmed that total STXBP1 expression is reduced in the adolescent mPFC relative to adults.
This alteration in STXBP1 expression in the adolescent mPFC was also observed in each addi-
tional brain region examined (dStr, NAc, M1, Amy and VTA), which may indicate that this
developmental change in STXBP1 levels is part of a brain-wide process, perhaps in response to
the widespread changes in neurotransmitter signaling reported throughout the brain during
adolescence [2]. The increased STXBP1 observed in the mature brain may contribute to
greater regulation of synaptic transmission in adults, and ultimately greater refinement in the
executive functioning of the PFC.
DNM1 participates in vesicle budding in both clathrin-mediated endocytosis and activity-
dependent bulk endocytosis [52, 53], and mutations in dynamin cause developmental abnor-
malities in drosophila [54]. Proteomic analysis of DNM1 revealed two individual spots that
were each identified as DNM1 (spot #4 and #6) As was the case for STXBP1, each spot was
identified as DNM1 with high confidence; spot #4 was identified as DNM1 with 22 peptides
and a peptide score of 338, and spot #6 was identified as DNM1 with 34 peptides and a peptide
score of 625. Unlike STXBP1, however, in this instance one DNM1 spot displayed increased
expression in the adult mPFC (spot #4) while the other showed increased expression in the
adolescent mPFC (spot #6). To resolve this apparent contradiction, immunoblotting for total
DNM1 protein showed that DNM1 expression was lower in the adolescent versus the adult
mPFC, consistent with spot #4. The increased expression in DNM1 at spot #6 may indicate
that a posttranslational modification of DNM1 has higher expression in the adolescent mPFC,
perhaps in compensation for reduced protein levels. Future studies should examine the phos-
phorylation state and activity of DNM1 in the adolescent and adult cortex to test this hypothe-
sis. Similar to STXBP1, Western blot analysis of total DNM1 expression in other brain regions
showed higher DNM1 expression in adults across most brain regions, with the exception of
the NAc where levels did not significantly differ between the two ages. Much like STXBP1, the
generally elevated expression of DNM1 in the adult brain may represent more mature control
of receptor expression at the cell surface and therefore refinement of synaptic signaling.
Whereas DPYSL2, STXBP1 and DNM1 showed a general decrease in the adolescent brain
relative to the adult brain, the expression of the focus protein cofilin-1 (CFL1) was found to
have higher expression in the adolescent prefrontal cortex in the proteomics analysis. Further-
more, the age-dependent alteration in CFL1 expression was relatively selective for the mPFC;
of the additional brain regions tested, only the VTA showed a similar age difference (Fig 8).
Spot 54 was identified as CFL1, but the 3D image rendered by DeCyder revealed a shoulder
onto another spot, and the candidate protein CFL2 was also a significant identity for Spot 54.
Ultimately CFL1 was chosen as the protein identity for Spot 54 based on the higher protein
score of CFL1 versus CFL2, and immunoblotting experiments confirmed that the expression
of CFL1 is increased in the adolescent mPFC versus the adult. However, the potential for CFL2
in addition to CFL1 being altered during adolescent brain development remains a strong
possibility.
Both cofilin-1 and -2 are actin depolymerizing proteins [55] that contribute to spine growth
and shrinkage [56, 57], cell migration [58] and AMPAR and NMDAR trafficking during both
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long-term potentiation (LTP) and long-term depression (LTD) [59, 60]. These observations
make cofilin a particularly interesting protein in the context of adolescent development of the
cortex and the developmental disorders associated with adolescent cortical disruption, such as
schizophrenia.
Schizophrenia is a psychotic disorder characterized by significant impairments in cogni-
tion, hallucinations and delusions, and social withdrawal and mood disturbances [61] that is
usually diagnosed during adolescence [62]. A significant neurobiological component of
schizophrenia appears to be alterations in cortical gray matter; schizophrenia patients present
with both faster reductions in cortical gray matter during adolescence [63] and greater total
volume reductions in the prefrontal cortex [64], which may predate symptom onset [65].
Decreased dendritic spines [66] and synaptic markers [67] have also been reported in the
schizophrenic cortex. Taken together, these findings suggest a “hyper-adolescent” state in the
schizophrenic cortex, such that adolescent-typical neural pruning occurs in excess [68], elimi-
nating necessary synaptic connections in the PFC and reducing ability to regulate brain func-
tion and behavior.
Several recent reports have linked actin dynamics and cofilin to schizophrenia [69, 70].
Additionally, Ingenuity Global Functional Analysis revealed significant enrichment of the
identified protein dataset for proteins previously shown to be linked to schizophrenia, includ-
ing GAP43 [71], VDAC1 [72] and SNCB [73], all of which have been shown to play a role in
synaptic communication. These results underscore the association between normal adolescent
brain development and pathology. However, neither the protein identifications nor the bioin-
formatics utilized in the present studies were able to assess a functional role for the observed
protein alterations either in normal development or in disease. A major goal for future work
will be the evaluation of protein targets like cofilin that may regulate adolescent brain develop-
ment and be mechanistically involved in the etiology of developmental disorders such as
schizophrenia.
Limitations and future directions
The most significant limitation of the present work was the inability to assess the functional
relevance of protein changes observed in these experiments. Although the identified proteins
and subsequent bioinformatics analyses provide insight into the biochemical processes that
may underlie the development occurring in the adolescent mPFC, these results are correla-
tional and do not directly address the causative relationship, if any, between protein expression
changes and structural/functional maturation. However, the high-throughput nature of the
proteomics analysis enabled the identification of several novel targets and signaling pathways,
providing significant heuristic value for subsequent investigations. The Ingenuity Pathway
Analysis provided useful insight into additional protein targets whose activity, but not expres-
sion, may be altered during adolescent brain development, but the suggested impact of devel-
opment on predicted interaction proteins was not directly assessed in these experiments.
Future work should confirm changes in the activity or phosphorylation state of protein pre-
dicted by IPA to be altered in the adolescent mPFC.
The proteomic screen was conducted using 2D-DIGE and MALDI TOF/TOF MS, a high-
throughput and cost-effective means of obtaining a “snapshot” of the mPFC proteome in ado-
lescent and adult samples. However, gel-based proteomics applications have important limita-
tions, the most significant of which are the inability to detect low-abundance proteins and the
difficulty of resolving membrane-bound proteins [74]. Several previous studies have examined
the synaptic fraction of the mPFC proteome in developing rodents [17–20], thus the present
findings add to a preexisting literature by shedding light on the whole-cell protein alterations
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occurring during adolescent brain maturation. Still, the methods used in these experiments
leave open the strong possibility that additional proteins not detected here may be altered dur-
ing cortical development.
Additionally, the immunoblots were developed with radiography, which presents limited
resolution compared with digital imaging systems. Subsequent experiments to expand the
present findings could strengthen the conclusions reported herein by combining MS-based
proteomics with digital imaging of immunoblots to confirm the protein expression changes
observed. In the immunoblot experiments, actin was selected as a housekeeping protein due to
its previous use as a loading control in development proteomics screens [18] and the lack of
evidence for age differences in actin expression in the present proteomics assessment. Across
all brain regions and proteins tested, the optical density of actin was not different between ado-
lescents and adults. Nevertheless, the actin values were not compared to total protein in the
immunoblot experiments, leaving open the possibility that loading errors could have occluded
a genuine age difference, rending actin inappropriate as a housekeeping protein. However,
four previous proteomics screen have failed to identify actin as developmentally altered during
adolescent brain development [17–20]. Combined with the consistent lack of age differences
in actin optical density observed in each brain region tested, the possibility of occult age differ-
ences in actin expression remains but seems unlikely.
During tissue collection, mice were perfused using 1.0M PBS to remove blood that could
potentially contaminate brain tissue and alter the protein differences reported in the proteo-
mics screen. However, this treatment entailed the use of an injected anesthetic, and injection
stress could have altered the expression of identified proteins, as could the perfusion process
itself. To avoid identifying age differences in proteins based on stress/perfusion alone, both
adolescent and adult samples were treated identically during anesthesia and perfusion. Still,
protein abundance in both ages could have been altered by these procedures.
Conclusion
The present findings supplement an existing body of work that suggests that adolescence is
characterized by enhancement of neural pruning, synaptic plasticity, and morphological
changes as the brain matures into adulthood. Importantly, many of the proteins identified in
the current experiments have previously been observed to be altered at the protein level in
mouse cortex [20] and at the gene expression level in the postmortem human adolescent cor-
tex [75]. The results of the proteomics analysis provide novel insight into a wider array of
molecular alterations that may underlie the large-scale alterations in cortical gray matter and
connectivity observed during adolescence. Further, functional protein networks involved in
cellular assembly and signaling point toward pathways for future research into the mechanistic
regulation of postnatal brain development. Future experiments to evaluate the role of the iden-
tified proteins and signaling systems in adolescent brain maturation, particularly in the context
of psychiatric diseases such as schizophrenia, will shed further light on this crucial develop-
mental period.
Supporting information
S1 Fig. DPYSL2 prefrontal cortex Western blots (DPYSL2-PFC). Photos represent the left
and right sides of a single 18-lane membrane.
(TIF)
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S2 Fig. DPYSL2 dorsal striatum Western blots (DPYSL2-dSTR). Photos represent the left
and right sides of a single 18-lane membrane.
(TIF)
S3 Fig. DPYSL2 nucleus accumbens Western blots (DPYSL2-NAc). Photos represent the left
and right sides of a single 18-lane membrane.
(TIF)
S4 Fig. DPSYL2 motor cortex Western blots (DPYSL2-MC). Photos represent the left and
right sides of a single 18-lane membrane.
(TIF)
S5 Fig. DPYSL2 amygdala Western blots (DPYSL2-AMY). Photos represent the left and
right sides of a single 18-lane membrane.
(TIF)
S6 Fig. DPSYL2 ventral tegmental area Western blots (DPYSL2-VTA). Photos represent
the left and right sides of a single 18-lane membrane.
(TIF)
S7 Fig. STXBP1 prefrontal cortex Western blots (STXBP1-PFC). Photos represent the left
and right sides of a single 18-lane membrane. Visible bands at ~100 kDa are Drebrin which
was probed on the same blot.
(TIF)
S8 Fig. STXBP1 dorsal striatum Western blots (STXBP1-dSTR). Photos represent the left
and right sides of a single 18-lane membrane.
(TIF)
S9 Fig. STXBP1 nucleus accumbens Western blots (STXBP1-NAc). Photos represent the
left and right sides of a single 18-lane membrane.
(TIF)
S10 Fig. STXBP1 motor cortex Western blots (STXBP1-MC). Photos represent the left and
right sides of a single 18-lane membrane.
(TIF)
S11 Fig. STXBP1 amygdala Western blots (STXBP1-AMY). Photos represent the left and
right sides of a single 18-lane membrane.
(TIF)
S12 Fig. STXBP1 ventral tegmental area Western blots (STXBP1-VTA). Photos represent
the left and right sides of a single 18-lane membrane.
(TIF)
S13 Fig. DNM1 prefrontal cortex Western blots (DNM1-PFC). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which was probed
on the same blot.
(TIF)
S14 Fig. DNM1 dorsal striatum Western blots (DNM1-dSTR). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which was probed
on the same blot.
(TIF)
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S15 Fig. DNM1 nucleus accumbens Western blots (DNM1-NAc). Photos represent the left
and right sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which was
probed on the same blot.
(TIF)
S16 Fig. DNM1 motor cortex Western blots (DNM1-MC). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which was probed
on the same blot.
(TIF)
S17 Fig. DNM1amygdala Western blots (DNM1-AMY). Photos represent the left and right
sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which was probed on
the same blot.
(TIF)
S18 Fig. DNM1 ventral tegmental area Western blots (DNM1-VTA). Photos represent the
left and right sides of a single 18-lane membrane. Visible bands at ~20 kDa are CFL1 which
was probed on the same blot.
(TIF)
S19 Fig. CFL1 prefrontal cortex Western blots (CFL1-PFC). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was
probed on the same blot.
(TIF)
S20 Fig. CFL1 dorsal striatum Western blots (CFL1-dSTR). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was
probed on the same blot.
(TIF)
S21 Fig. CFL1 nucleus accumbens Western blots (CFL1-NAc). Photos represent the left and
right sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was
probed on the same blot.
(TIF)
S22 Fig. CFL1 motor cortex Western blots (CFL1-MC). Photos represent the left and right
sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was probed
on the same blot.
(TIF)
S23 Fig. CFL1 amygdala Western blots (CFL1-AMY). Photos represent the left and right
sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was probed
on the same blot.
(TIF)
S24 Fig. CFL1 ventral tegmental area Western blots (CFL1-VTA). Photos represent the left
and right sides of a single 18-lane membrane. Visible bands at ~100kDa are DNM1 which was
probed on the same blot.
(TIF)
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